Entrada Therapeutics (TRDA) Net Equity Issued and Repurchased (2021 - 2024)
Entrada Therapeutics (TRDA) posted quarterly Net Equity Issued and Repurchased of -$392000.0 for Q3 2024, down 100.39% quarter-over-quarter from $100.0 million in Q2 2024.
Entrada Therapeutics (TRDA) Net Equity Issued and Repurchased (2021 - 2024) Analysis & Trends
Entrada Therapeutics' Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at -$392000.0 for Q3 2024.
- In Q3 2024, Net Equity Issued and Repurchased changed N/A year-over-year to -$392000.0; the TTM figure through Dec 2025 stood at -$392000.0 (down 100.39% YoY), while the FY2024 annual figure was $99.6 million, up 413.26% from the prior year.
- Net Equity Issued and Repurchased for Q3 2024 stood at -$392000.0, down from $100.0 million in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $116.2 million in Q1 2021, with the low at -$417000.0 in Q2 2021.
- The 3-year median for Net Equity Issued and Repurchased is $19.4 million (2023), against an average of $47.0 million.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 141.90 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Entrada Therapeutics | 290.47 Mn | 290.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -392,000.00 |
| Sep 30, 2024 | -392,000.00 |
| Jun 30, 2024 | 100.00 Mn |
| Jun 30, 2024 | 100.00 Mn |
| Mar 31, 2023 | 19.41 Mn |
| Mar 31, 2023 | 19.41 Mn |
| Jun 30, 2021 | -417,000.00 |
| Jun 30, 2021 | -417,000.00 |
| Mar 31, 2021 | 116.25 Mn |
| Mar 31, 2021 | 116.25 Mn |